Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Scientific Session

Vasculitis
General Topic: Clinical Science

13M171: Vasculitis Cookbook

Monday, November 13, 2023
4:00 PM – 5:30 PM PT
Location: Room 6A-B
CE: 1.5

In Person On Demand

    Speaker(s)

  • Anisha Dua, MD, MPH

    Northwestern University
    Chicago, IL, United States

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)

  • TK

    Tanaz Kermani, MD, MS

    University of California Los Angeles
    Santa Monica, CA, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • AV

    Alexandra Villa-Forte, MD, MPH, FACP

    Cleveland Clinic
    Cleveland, OH, United States

    Disclosure(s): Amgen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

For the practicing clinician caring for a patient with systemic vasculitis, evidence-based medicine only takes you so far. Clinical trials often fail to address specific scenarios encountered by rheumatologists delivering clinical care. In this session, three expert clinicians will discuss how they manage patients with specific forms of systemic vasculitis and demonstrate how they bridge the gap between clinical trials and clinical practice. For each disease, the discussants will provide concrete recommendations for remission induction and remission maintenance strategies, guidance regarding monitoring patients, and key insights into the management of common scenarios not directly addressed by clinical trials.

Learning Objectives:

  • Discuss the initial treatment of eosinophilic granulomatosis with polyangiitis and the management of specific manifestations of the disease.
  • Examine the initial treatment of granulomatosis with polyangiitis (GPA) and the appropriate management of GPA-associated damage.
  • Discuss the initial treatment of Takayasu’s arteritis and management strategies for refractory disease.

Presentations:

  • 4:00 PM – 4:20 PM PT
    Eosinophilic Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine

    Speaker: Anisha Dua, MD, MPH – Northwestern University

  • 4:20 PM – 4:30 PM PT
    Q&A
  • 4:30 PM – 4:50 PM PT
    Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine

    Speaker: Alexandra Villa-Forte, MD, MPH, FACP – Cleveland Clinic

  • 4:50 PM – 5:00 PM PT
    Q&A
  • 5:00 PM – 5:20 PM PT
    Takayasu's Arteritis: Beyond Evidence-Based Medicine

    Speaker: Tanaz Kermani, MD, MS – University of California Los Angeles

  • 5:20 PM – 5:30 PM PT
    Q&A